China Collaborative Study on Epidemiology of Acute Kidney Injury
- Conditions
- Acute Kidney Injury
- Interventions
- Other: no intervention
- Registration Number
- NCT03054142
- Lead Sponsor
- XinLing Liang
- Brief Summary
Acute kidney injury (AKI) is a common clinical syndrome, especially patients in the hospital. AKI has become a huge medical burden in China. Little information is available about this disease burden in our country. The investigators aimed to evaluate the burden of AKI and to analyze the related risk factors.
- Detailed Description
The investigators launch a nationwide of all patients, who were admitted to hospital from 2011-2016. Patients were diagnosed on the basis of changes in serum creatinine by the laboratory information system. The investigators assessed rates of AKI according to the criteria of 2012 Kidney Disease Improving Global Outcomes (KDIGO).
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1000000
- The patients diagnosed on the basis of changes in serum creatinine according to the criteria of 2012 Kidney Disease Improving Global Outcomes(KDIGO)
- Serum creatinine record less than two times during hospitalization
- Patients being diagnosed with End-stage kidney disease (chronic kidney disease stage 5)
- Nephrectomy
- Kidney transplantation
- Peak serum creatinine of less than 53µ mol/L
- Serum creatinine decrease after amputation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description non-AKI no intervention - AKI no intervention -
- Primary Outcome Measures
Name Time Method Incidence of AKI Jan. 2011 to Oct. 2016
- Secondary Outcome Measures
Name Time Method Longer ICU stay Jan. 2011 to Oct. 2016 In-hospital mortality Jan. 2011 to Oct. 2016 Recognition rate of AKI Jan. 2011 to Oct. 2016 Using machine learning and deep learning methods to establish AKI prediction model and risk models
Proportion of nephrology referral Jan. 2011 to Oct. 2016 Higher medical cost Jan. 2011 to Oct. 2016
Trial Locations
- Locations (1)
Nephrology Dept,Guangdong General Hospital
🇨🇳Guangzhou, Guangdong, China